Bio

Bio


Dr. Htet is a fellow physician of Critical Care Medicine. She earned her undergraduate degree in Biochemistry and Neuroscience at University of California Los Angeles (UCLA) and her masters degree in Physiological Science at UCLA. She received her M.D. degree from the University of Wisconsin School of Medicine and Public Health. During medical school, she was a part of leadership team for free clinics in the area, and performed research in the field of neuroimaging concurrent with her interest in undergraduate and graduate studies. She did her residency in Emergency Medicine at Advocate Christ Medical Center in Oak Lawn, near Chicago. During residency, she continued her interest in research and teaching, and was selected to be a chief resident. She was involved in national emergency medicine organizations and mentor groups. She started her fellowship training in Critical Care Medicine at Stanford in 2016 and works in intensive care units at Stanford, Veteran Affairs Hospital in Palo Alto, and Santa Clara Valley hospital. Her career interests involve teaching, palliative care, new models of improving patient education, and continued research in hemodynamic monitoring and neurocritical care.

Clinical Focus


  • Critical Care
  • Medical Education
  • Patient education
  • Palliative Care
  • Critical Care Medicine

Academic Appointments


Honors & Awards


  • Emergency Medicine Foundation Grant, Advocate Christ Medical Center (2015)
  • Emergency Medicine Foundation Grant, Advocate Christ Medical Center (2014)
  • Don Bruechert Medical Scholarship, University of Wisconsin School of Medicine and Public Health (2012)
  • Student Leadership and Service Book Award, University of Wisconsin School of Medicine and Public Health (2011)
  • Shapiro Research Award, University of Wisconsin School of Medicine and Public Health (2010)

Boards, Advisory Committees, Professional Organizations


  • Member, American Thoracic Society (2017 - Present)
  • Member, American College of Emergency Physicians (2013 - Present)

Professional Education


  • Fellowship:Stanford University Pulmonary and Critical Care Fellowship (2018) CA
  • Board Certification: Emergency Medicine, American Board of Emergency Medicine (2017)
  • Residency:Advocate Christ Medical Center (2016) IL
  • Medical Education:University of Wisconsin Madison Office of the Registrar (2013) WI
  • M.D., University of Wisconsin School of Medicine and Public Health, Medicine (2013)
  • Residency, Advocate Christ Medical Center, Emergency Medicine (2016)
  • Fellowship, Stanford Medicine Critical Care Fellowship, Critical Care Medicine (2018)

Community and International Work


  • MEDiC (Student-Run Free Medical Clinics), Madison

    Topic

    Vice President-Finance

    Populations Served

    underserved

    Location

    US

    Ongoing Project

    No

    Opportunities for Student Involvement

    No

Research & Scholarship

Current Research and Scholarly Interests


Hemodynamic monitoring; axillary art line; FEIBA; video education

Publications

All Publications


  • Needle-guided ultrasound technique for axillary artery catheter placement in critically ill patients: A case series and technique description. Journal of critical care Htet, N., Vaughn, J., Adigopula, S., Hennessey, E., Mihm, F. 2017; 41: 194-197

    Abstract

    Axillary arterial cannulation for blood pressure monitoring has been reported in adults since 1973. Reported failure rates using palpation landmarks are high. This report describes a needle-guided ultrasound technique for axillary arterial line placement in critically ill patients.A retrospective review of all patients requiring axillary arterial cannulation attempts with ultrasound-assisted needle guidance for hemodynamic monitoring was performed from July 2010 to June 2016 at a single institution.One hundred fifty nine (159) cannulation attempts were performed in 155 patients. The overall success rate was 97%, with a first pass success rate of 84%. Inexperienced operators performed 49% of procedures under direct faculty supervision, and had a 99% success rate, which was not different from experienced operators. Almost 20% of patients had moderate-to-severe coagulopathy (platelets<50k/uL, INR>2.0 or PTT>60s). Complications reported included the following: nonfunctioning of catheter (6%) and hematoma (6%). Ischemia was noted in 2 patients (1%), but only one was attributed to the arterial catheter.Use of the needle-guided ultrasound assisted approach for axillary arterial line placement is easily teachable and can be used to promote safe and successful placement of axillary arterial lines for novice learners.

    View details for DOI 10.1016/j.jcrc.2017.05.026

    View details for PubMedID 28577475

  • Biodistribution and predictive value of (IF)-I-18-fluorocyclophosphamide in mice bearing human breast cancer xenografts JOURNAL OF NUCLEAR MEDICINE Kesner, A. L., Hsueh, W., Htet, N. L., Pio, B. S., Czernin, J., Pegram, M. D., Phelps, M. E., Silverman, D. H. 2007; 48 (12): 2021-2027

    Abstract

    In mice bearing human breast cancer xenografts, we examined the biodistribution of (18)F-fluorocyclophosphamide ((18)F-F-CP) to evaluate its potential as a noninvasive prognostic tool for predicting the resistance of tumors to cyclophosphamide therapy.(18)F-F-CP was synthesized as we recently described, and PET data were acquired after administration of (18)F-F-CP in mice bearing human breast cancer xenografts (MCF-7 cells). Tracer biodistribution in reconstructed images was quantified by region-of-interest analysis. Distribution was also assessed by harvesting dissected organs, tumors, and blood, determining (18)F content in each tissue with a gamma-well counter. The mice were subsequently treated with cyclophosphamide, and tumor size was monitored for at least 3 wk after chemotherapy administration.The distribution of harvested activity correlated strongly with distribution observed in PET images. Target organs were related to routes of metabolism and excretion. (18)F-F-CP uptake was highest in kidneys, lowest in brain, and intermediate in tumors, as determined by both image-based and tissue-based measurements. (18)F-F-CP uptake was not inhibited by coadministration of an approximately x700 concentration of unlabeled cyclophosphamide. PET measures of (18)F-F-CP uptake in tumor predicted the magnitude of the response to subsequent administration of cyclophosphamide.Noninvasive assessment of (18)F-F-CP uptake using PET may potentially be helpful for predicting the response of breast tumors to cyclophosphamide before therapy begins.

    View details for DOI 10.2967/jnumed.107.045716

    View details for Web of Science ID 000252895100020

    View details for PubMedID 18006620

Footer Links:

Stanford Medicine Resources: